Patents by Inventor Matt A. Curry

Matt A. Curry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Aryl and heteroaryl substituted tetrahydroisoquinolines and use thereof
    Patent number: 7612090
    Abstract: Provided herein are compounds of the formula (I): wherein R1-R8 are as described herein, R4 being aryl or heteroaryl Such compounds are particularly useful in the treatment of a disorder which is created by or is dependent upon decreased availability of serotonin, norepinephrine or dopamine.
    Type: Grant
    Filed: April 29, 2003
    Date of Patent: November 3, 2009
    Assignee: Albany Molecular Research, Inc.
    Inventors: James P. Beck, Matt A. Curry, Mark A. Smith
  • Aryl and heteroaryl substituted tetrahydroisoquinolines and use thereof
    Patent number: 7265116
    Abstract: Provided herein are compounds of the formula (I): wherein R1-R8 are as described herein, R4 being phthalazinyl, pyrazinyl, pyridazinyl, or quinoxalinyl. Such compounds are particularly useful in the treatment of a disorder which is created by or is dependent upon decreased availability of serotonin, norepinephrine, or dopamine.
    Type: Grant
    Filed: August 13, 2004
    Date of Patent: September 4, 2007
    Assignee: ARM Technology, Inc.
    Inventors: James P. Beck, Matt A. Curry, Mark A. Smith
  • Aryl and heteroaryl substituted tetrahydroisoquinolines and use thereof
    Publication number: 20030203920
    Abstract: Provided herein are compounds of the formula (I): 1
    Type: Application
    Filed: April 29, 2003
    Publication date: October 30, 2003
    Inventors: James P. Beck, Matt A. Curry, Mark A. Smith
  • Aryl and heteroaryl substituted tetrahydroisoquinolines and use thereof
    Patent number: 6579885
    Abstract: Provided herein are compounds of the formula (I): wherein R1-R8 are as described herein, R4 being aryl or heteroaryl Such compounds are particularly useful in the treatment of a disorder which is created by or is dependent upon decreased availability of serotonin, norepinephrine or dopamine.
    Type: Grant
    Filed: March 6, 2002
    Date of Patent: June 17, 2003
    Assignee: Albany Molecular Research, Inc.
    Inventors: James P. Beck, Matt A. Curry, Mark A. Smith
  • Aryl and heteroaryl substituted tetrahydroisoquinolines and use thereof
    Publication number: 20020143014
    Abstract: Provided herein are compounds of the formula (I): 1
    Type: Application
    Filed: March 6, 2002
    Publication date: October 3, 2002
    Inventors: James P. Beck, Matt A. Curry, Mark A. Smith